The Malaysian Reserve

Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care

Enzyme Replacement Therapy (ERT) generated over US$ 46 billion in 2024, driven by established treatments for Gaucher disease, ...